TRIP Clinical Trial: Uncovering a Novel Therapeutic Target to Reduce Dementia Risk in Parkinson’s disease

Cognitive impairment and dementia are a top concern for people living with Parkinson’s disease (PD). The TRIP study explores a potential treatment for mild memory impairment with the overall aim of reducing dementia risk in Parkinson’s disease.